Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fridays vs GetRelief Rx

Fridays
Site position #202

Higher grade

vs+7.8
GetRelief Rx
Site position #401

Lower grade

The verdict

Fridays takes it — 66.7/100 to 58.9/100.

Fridays grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fridays is strongest for shoppers who will use its dietitian and coaching support. Compare the regular monthly plan first: the lowest advertised equivalent is tied to annual payment.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFridays +15
58
43
Dose & formulationFridays +10
88
78
Clinical oversightFridays +2
72
70
Labs & monitoringFridays +1
53
52
FulfillmentFridays +7
65
58
Contract termsFridays +8
55
47
Fridays · left barGetRelief Rx · right bar

The numbers

MetricFridaysGetRelief Rx
WeighScore66.7/10058.9/100
GradeCC
Site position#202#401
Semaglutide$249/mo month-to-month; from $150/mo paid annually$269/mo (9 mg dose, compounded oral)
Tirzepatide$359/mo month-to-month; from $240/mo paid annually$179/mo (16 mg dose, compounded oral)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Fridays

Site position #202 · C

Strengths

  • Publishes compounded monthly versus annual-plan pricing
  • Offers branded treatments, including a Wegovy pill membership route
  • Includes provider visits and dietitian support

Where it loses points

  • Annual rates require a larger commitment
  • Wegovy membership promotion excludes medication cost
  • Separate four-month membership promotions have their own renewal terms
GetRelief Rx

Site position #401 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard